Debt-to-equity of NexImmune, Inc. from 30 Sep 2021 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NexImmune, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Jun 2024.
  • NexImmune, Inc. Debt-to-equity for the quarter ending 30 Jun 2024 was 147%, a 417% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NexImmune, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 147% +119% +417% 30 Jun 2024
Q1 2024 76% +52% +221% 31 Mar 2024
Q4 2023 48% +29% +156% 31 Dec 2023
Q3 2023 38% +24% +178% 30 Sep 2023
Q2 2023 28% +18% +169% 30 Jun 2023
Q1 2023 24% +16% +203% 31 Mar 2023
Q4 2022 19% +12% +192% 31 Dec 2022
Q3 2022 14% -4% -24% 30 Sep 2022
Q2 2022 11% 30 Jun 2022
Q1 2022 8% 31 Mar 2022
Q4 2021 6% 31 Dec 2021
Q3 2021 18% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.